Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
7,711
archived clinical trials in
Depression

A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lauderhill, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Maitland, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Melbourne, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
North Miami, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oakland Park, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Orlando, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Orlando, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Tampa, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
West Palm Beach, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
West Palm Beach, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Winter Haven, FL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Winter Haven, FL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes, Investigational Site
mi
from
Alpharetta, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes, Investigational Site
mi
from
Alpharetta, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Atlanta, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Decatur, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Smyrna, GA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Smyrna, GA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Study Site
mi
from
Chicago, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Joliet, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Joliet, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Oak Brook, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Oak Brook, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Skokie, IL
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Skokie, IL
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Indianapolis, IN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Lafayette, IN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Lafayette, IN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Newburgh, IN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Newburgh, IN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Valparaiso, IN
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Valparaiso, IN
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Edgewood, KY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Edgewood, KY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Owensboro, KY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Owensboro, KY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Baltimore, MD
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Baltimore, MD
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Baltimore, MD
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Washington D.C., MD
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Washington D.C., MD
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Brockton, MA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Brockton, MA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Watertown, MA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Watertown, MA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Worcester, MA
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Worcester, MA
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Flowood, MS
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
O'Fallon, MO
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
O'Fallon, MO
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Berlin, NJ
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Cherry Hill, NJ
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Cherry Hill, NJ
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Princeton, NJ
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Princeton, NJ
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Albuquerque, NM
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Albuquerque, NM
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Brooklyn, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Brooklyn, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Jamaica, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Jamaica, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Mount Kisco, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Mount Kisco, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
New York, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Staten Island, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Staten Island, NY
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Staten Island, NY
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Charlotte, NC
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
High Point, NC
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
High Point, NC
Click here to add this to my saved trials
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated:  12/31/1969
Alkermes Investigational Site
mi
from
Beachwood, OH
A Long-Term Safety Study of ALKS 5461
A Phase 3 Multicenter Study of the Long-Term Safety and Tolerability of ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder in Adults Who Have an Inadequate Response to Antidepressant Therapy (the FORWARD-2 Study)
Status: Enrolling
Updated: 12/31/1969
Alkermes Investigational Site
mi
from
Beachwood, OH
Click here to add this to my saved trials